Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Manganese(ii) Sulfate
2. 7785-87-7
3. Manganous Sulfate
4. Manganese(2+) Sulfate
5. Manganese Monosulfate
6. Manganese Sulfate Anhydrous
7. Manganese Sulfate (1:1)
8. Mnso4
9. 10124-55-7
10. Manganese(2+);sulfate
11. Manganese(2+) Sulfate (1:1)
12. Iga15s9h40
13. Sorba-spray Mn
14. Man-gro
15. Sorba-spray Manganese
16. Sulfuric Acid, Manganese Salt
17. Manganese (ii) Sulfate Solution
18. Manganese Sulfate (mnso4)
19. Sulfato De Manganeso
20. Ccris 6916
21. Hsdb 2187
22. Nci C61143
23. Einecs 232-089-9
24. Unii-iga15s9h40
25. Sulfuric Acid, Manganese (ii) Salt (1:1)
26. Manganese(ii) Sulfate (1:1)
27. Einecs 233-342-6
28. Manganese(ii)sulfate
29. Manganese(ii) Sulphate
30. Manganese(2+) Sulphate
31. Ec 232-089-9
32. Manganese Sulfate [mi]
33. Dtxsid9044160
34. Chebi:86360
35. Manganese(ii) Sulfate (mnso4)
36. Manganese (ii )sulfate Anhydrous
37. Manganese Sulfate [who-dd]
38. Manganese Sulphate Anhydrous
39. Manganese Sulfate, Anhydrous
40. Manganese Sulfate (anhydrous)
41. Mangani(ii) Sulfas Anhydricus
42. Akos015904462
43. Manganese (as Sulfate) [vandf]
44. Manganese(2+) Sulphate (1:1)
45. Manganese Sulfate Anhydrous [hsdb]
46. Ft-0628155
47. M3394
48. Q409393
49. J-521672
Molecular Weight | 151.00 g/mol |
---|---|
Molecular Formula | MnO4S |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 150.889773 g/mol |
Monoisotopic Mass | 150.889773 g/mol |
Topological Polar Surface Area | 88.6 Ų |
Heavy Atom Count | 6 |
Formal Charge | 0 |
Complexity | 62.2 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
MEDICATION (VET): To prevent or treat manganese deficiency.
Reynolds, J.E.F., Prasad, A.B. (eds.) Martindale-The Extra Pharmacopoeia. 28th ed. London: The Pharmaceutical Press, 1982., p. 937
MEDICATION (VET): NUTRITIONAL FACTOR (ESSENTIAL TRACE ELEMENT IN ALL ANIMALS); PREVENTION OF PEROSIS IN POULTRY.
The Merck Index. 10th ed. Rahway, New Jersey: Merck Co., Inc., 1983., p. 818
MEDICATION: NUTRIENT &/OR DIETARY SUPPLEMENTAL FOOD ADDITIVE
Furia, T.E. (ed.). CRC Handbook of Food Additives. 2nd ed. Cleveland: The Chemical Rubber Co., 1972., p. 383
WHEN LARGE DOSES OF MANGANESE SULFATE ARE INJECTED IV EXCRETION IS ALMOST EXCLUSIVELY IN FECES ... .
Browning, E. Toxicity of Industrial Metals. 2nd ed. New York: Appleton-Century-Crofts, 1969., p. 215
/Manganese sulfate/ is poorly absorbed through lung and gut.
Gosselin, R.E., R.P. Smith, H.C. Hodge. Clinical Toxicology of Commercial Products. 5th ed. Baltimore: Williams and Wilkins, 1984., p. II-144
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
66
PharmaCompass offers a list of Manganese Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Manganese Sulfate manufacturer or Manganese Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Manganese Sulfate manufacturer or Manganese Sulfate supplier.
PharmaCompass also assists you with knowing the Manganese Sulfate API Price utilized in the formulation of products. Manganese Sulfate API Price is not always fixed or binding as the Manganese Sulfate Price is obtained through a variety of data sources. The Manganese Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Manganese sulfate anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Manganese sulfate anhydrous, including repackagers and relabelers. The FDA regulates Manganese sulfate anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Manganese sulfate anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Manganese sulfate anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Manganese sulfate anhydrous supplier is an individual or a company that provides Manganese sulfate anhydrous active pharmaceutical ingredient (API) or Manganese sulfate anhydrous finished formulations upon request. The Manganese sulfate anhydrous suppliers may include Manganese sulfate anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of Manganese sulfate anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Manganese sulfate anhydrous DMF (Drug Master File) is a document detailing the whole manufacturing process of Manganese sulfate anhydrous active pharmaceutical ingredient (API) in detail. Different forms of Manganese sulfate anhydrous DMFs exist exist since differing nations have different regulations, such as Manganese sulfate anhydrous USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Manganese sulfate anhydrous DMF submitted to regulatory agencies in the US is known as a USDMF. Manganese sulfate anhydrous USDMF includes data on Manganese sulfate anhydrous's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Manganese sulfate anhydrous USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Manganese sulfate anhydrous suppliers with USDMF on PharmaCompass.
A Manganese sulfate anhydrous CEP of the European Pharmacopoeia monograph is often referred to as a Manganese sulfate anhydrous Certificate of Suitability (COS). The purpose of a Manganese sulfate anhydrous CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Manganese sulfate anhydrous EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Manganese sulfate anhydrous to their clients by showing that a Manganese sulfate anhydrous CEP has been issued for it. The manufacturer submits a Manganese sulfate anhydrous CEP (COS) as part of the market authorization procedure, and it takes on the role of a Manganese sulfate anhydrous CEP holder for the record. Additionally, the data presented in the Manganese sulfate anhydrous CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Manganese sulfate anhydrous DMF.
A Manganese sulfate anhydrous CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Manganese sulfate anhydrous CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Manganese sulfate anhydrous suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Manganese sulfate anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Manganese sulfate anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Manganese sulfate anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Manganese sulfate anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Manganese sulfate anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Manganese sulfate anhydrous suppliers with NDC on PharmaCompass.
Manganese sulfate anhydrous Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Manganese sulfate anhydrous GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Manganese sulfate anhydrous GMP manufacturer or Manganese sulfate anhydrous GMP API supplier for your needs.
A Manganese sulfate anhydrous CoA (Certificate of Analysis) is a formal document that attests to Manganese sulfate anhydrous's compliance with Manganese sulfate anhydrous specifications and serves as a tool for batch-level quality control.
Manganese sulfate anhydrous CoA mostly includes findings from lab analyses of a specific batch. For each Manganese sulfate anhydrous CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Manganese sulfate anhydrous may be tested according to a variety of international standards, such as European Pharmacopoeia (Manganese sulfate anhydrous EP), Manganese sulfate anhydrous JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Manganese sulfate anhydrous USP).